ISMPP Highlights
Recent ISMPP Member Publications and Presentations
ISMPP is pleased to share several recent publications and presentations by Society members. We encourage our members to publish and present research and information related to publishing practices to advance the medical publications profession, and improve standards and best practices…
Keynote Speakers Present on Cutting-Edge Topics at ISMPP’s 13th Annual Meeting
ISMPP is pleased to introduce its distinguished keynote speakers for our 13th Annual Meeting, May 1-3, 2017, at the Gaylord National Resort & Convention Center, National Harbor, MD, USA. The enlightening keynote presentations will address various cutting-edge topics in medical publications, including…
Transparency Matters – Take the Transparency Pledge!
Transparency Matters is a call to action launched by Medical Publishing Insights & Practices (MPIP), designed to raise awareness, provide resources, and improve the quality and transparency in reporting the results of industry-sponsored research. Similar to ISMPP, Transparency Matters seeks to…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
The Truth, the Whole Truth, or “About Half” of the Truth: AllTrials and TrialsTracker
Criticism of pharmaceutical industry sponsored clinical trials tends to fall into two main areas, summed up by sentences such as “About half of all randomized clinical trials are never published, and the other half is often published selectively” – results disclosure and selective reporting. In the current climate of calls for improved clinical trials transparency…
Clinical Trials: An Overview of the Bread and Butter of Publications
The first reference to a clinical trial can be found in the Bible. In that trial, conducted by King Nebuchadnezzar II (605-562 BC), children fed a strict diet of meat and wine were compared to children fed pulses (eg, beans, peas, lentils) and followed for 3 years (by the way, the children on the meat and wine diet were deemed healthier)…
RWE: A Brave New World for the Medical Publications Professional
Real-World Evidence (RWE), according to the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), comprises “Data used for decision-making that are not collected in conventional randomized controlled trials (RCTs).” RWE is not new; collection of RWE has been mandated for the pharmaceutical industry for many years…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL: Delayed Review Calls Authorship into Question
You are a company medical publication professional. The lead author of a manuscript in development was key in acquiring data for the study and actively engaged in the initial discussions that shaped the outline for the paper. However, he/she was slow to send feedback…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals